Trump tears up TPP, but markets shun shredding to hit all-time highs

Published 25-JAN-2017 15:36 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Global markets shook off all the political ructions of the last week to post strong gains, particularly in the US where the NASDAQ (5600 points) and S&P 500 index (2280 points) hit record highs.

The Dow charged towards the psychological 20,000 point mark, hitting an intraday high of 19,949 points, a gain of 150 points on the previous day’s close. While it retraced slightly in the last hour of trading, positive sentiment prevailed.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering stocks in these markets should seek independent financial advice.

In the UK, the FTSE 100 finished relatively flat, but an important ruling regarding Brexit was released. The UK Supreme Court upheld a High Court ruling determined in early November which said that the British Parliament should be consulted before the government invokes Article 50, the beginning of the process for Britain to exit the European Union.

This was contrary to the expectations of British Prime Minister, Theresa May who was of the view that the government had the authority to trigger the process without independent legal approval.

These events have been welcomed as most analysts expect that such a procedure may lead to a softer Brexit landing.

In mainland Europe, key markets were mainly in positive territory with the Dax up 0.4% and the Paris CAC 40 gaining 0.4%.

More positive sentiment resulted in a softening in the gold price which fell from the previous day’s close of US$1218 per ounce to approximately US$1212 per ounce as US markets closed.

TPP – what TPP – Our commodities are going gangbusters and China is the main game

DonaldTrump

Futures markets are pointing to a strong opening on the ASX on the back of robust commodity prices. On the political front the focus now appears to be on China and the potential to established partnerships with other countries that were part of the TPP.

Positive sentiment from yesterday’s spike in Chinese iron ore futures could well spill over into trading today, bringing Rio Tinto, BHP Billiton and Fortescue Metals Group under the microscope.

While the oil price only finished up circa 0.6%, it traded as high as US$53.56 per barrel in early afternoon trading.

On the base metals front copper had a particularly strong run, eclipsing its 30 day high to close at US$2.67 per pound, just shy of US$2.70 per pound, a level it hasn’t traded at since 2015.

Zinc continued to make new 30 day highs as it put on approximately 1% to finish at US$1.27 per pound.

Lead continued its march and is now broadly in line with 2012 levels.

Even out of favour nickel regained some ground, increasing from the previous day’s close of US$4.38 per pound to close at US$4.42 per pound.

The Australian dollar continues to trade in a tight range between US$0.75 and US$0.76.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X